Skip to main navigation Skip to search Skip to main content

Electroporation of CRISPR-Cas9 into Malignant B Cells for Loss-of-Function Studies of Target Gene Via Knockout

  • Jian Yu*
  • *Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

CRISPR-Cas9 is a unique technology that enables geneticists and medical researchers to edit genomic DNA for studying biology, pathogenesis, and molecular basis of treatment in malignant B cells. Unfortunately, malignant B cells are extremely difficult to transfect by most traditional methods. In this chapter, we describe the use of the Nucleofector™ Technology-based electroporation system with optimized transfection conditions for generating a malignant B cell model, JEKO-1, with ROR1-gene knockout via CRISPR-Cas9 technology.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages85-90
Number of pages6
DOIs
StatePublished - 2020

Publication series

NameMethods in Molecular Biology
Volume2050
ISSN (Print)1064-3745
ISSN (Electronic)1940-6029

Keywords

  • CRISPR-Cas9
  • Electroporation
  • JEKO-1
  • Nucleofector

Fingerprint

Dive into the research topics of 'Electroporation of CRISPR-Cas9 into Malignant B Cells for Loss-of-Function Studies of Target Gene Via Knockout'. Together they form a unique fingerprint.

Cite this